CN110636830A - 天然糖基化多酚作为抗紫外线辐照影响的保护剂的用途 - Google Patents
天然糖基化多酚作为抗紫外线辐照影响的保护剂的用途 Download PDFInfo
- Publication number
- CN110636830A CN110636830A CN201780090820.6A CN201780090820A CN110636830A CN 110636830 A CN110636830 A CN 110636830A CN 201780090820 A CN201780090820 A CN 201780090820A CN 110636830 A CN110636830 A CN 110636830A
- Authority
- CN
- China
- Prior art keywords
- use according
- polyphenol
- concentration
- polyphenols
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 68
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 68
- 230000005855 radiation Effects 0.000 title claims abstract description 17
- 230000000694 effects Effects 0.000 title claims abstract description 8
- 239000003223 protective agent Substances 0.000 title claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 3
- 239000000516 sunscreening agent Substances 0.000 claims description 19
- 230000000475 sunscreen effect Effects 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 230000003711 photoprotective effect Effects 0.000 claims description 11
- 229930015704 phenylpropanoid Natural products 0.000 claims description 9
- 230000004224 protection Effects 0.000 claims description 9
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 claims description 8
- 230000006378 damage Effects 0.000 claims description 8
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 6
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 6
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims description 6
- 229960004555 rutoside Drugs 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 claims description 5
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 5
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 claims description 5
- 229940015301 baicalein Drugs 0.000 claims description 5
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 claims description 5
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 5
- 235000005493 rutin Nutrition 0.000 claims description 5
- 231100000419 toxicity Toxicity 0.000 claims description 5
- 230000001988 toxicity Effects 0.000 claims description 5
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 5
- KDSWDGKIENPKLB-QJDQKFITSA-N verbascoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)CCC=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O KDSWDGKIENPKLB-QJDQKFITSA-N 0.000 claims description 5
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 claims description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 4
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 235000006708 antioxidants Nutrition 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- KQNGHARGJDXHKF-UHFFFAOYSA-N dihydrotamarixetin Natural products C1=C(O)C(OC)=CC=C1C1C(O)C(=O)C2=C(O)C=C(O)C=C2O1 KQNGHARGJDXHKF-UHFFFAOYSA-N 0.000 claims description 4
- 229930003935 flavonoid Natural products 0.000 claims description 4
- 150000002215 flavonoids Chemical class 0.000 claims description 4
- 235000017173 flavonoids Nutrition 0.000 claims description 4
- 235000007708 morin Nutrition 0.000 claims description 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- HSTZMXCBWJGKHG-UHFFFAOYSA-N (E)-piceid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- 150000001299 aldehydes Chemical group 0.000 claims description 3
- 229960003764 polydatin Drugs 0.000 claims description 3
- HSTZMXCBWJGKHG-CUYWLFDKSA-N trans-piceid Polymers O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-CUYWLFDKSA-N 0.000 claims description 3
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 claims description 2
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 claims description 2
- 206010063493 Premature ageing Diseases 0.000 claims description 2
- 208000032038 Premature aging Diseases 0.000 claims description 2
- 230000006750 UV protection Effects 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 claims description 2
- 238000004113 cell culture Methods 0.000 claims description 2
- 239000003246 corticosteroid Substances 0.000 claims description 2
- 229960001334 corticosteroids Drugs 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 235000011987 flavanols Nutrition 0.000 claims description 2
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims description 2
- 150000007946 flavonol Chemical class 0.000 claims description 2
- 235000011957 flavonols Nutrition 0.000 claims description 2
- 230000007774 longterm Effects 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 230000036407 pain Effects 0.000 claims description 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 17
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 13
- 239000000126 substance Substances 0.000 description 11
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 9
- 150000002338 glycosides Chemical class 0.000 description 8
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 7
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 7
- 235000005875 quercetin Nutrition 0.000 description 7
- 229960001285 quercetin Drugs 0.000 description 7
- 229930000044 secondary metabolite Natural products 0.000 description 7
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- 238000006552 photochemical reaction Methods 0.000 description 6
- -1 aromatic polyphenols Chemical class 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 125000001474 phenylpropanoid group Chemical group 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 4
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 4
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000005281 excited state Effects 0.000 description 4
- 230000013595 glycosylation Effects 0.000 description 4
- 238000006206 glycosylation reaction Methods 0.000 description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 4
- 239000003504 photosensitizing agent Substances 0.000 description 4
- OIUBYZLTFSLSBY-HMGRVEAOSA-N quercetin 4'-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)C=C1O OIUBYZLTFSLSBY-HMGRVEAOSA-N 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 235000021283 resveratrol Nutrition 0.000 description 4
- 229940016667 resveratrol Drugs 0.000 description 4
- 150000003505 terpenes Chemical class 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229940093797 bioflavonoids Drugs 0.000 description 3
- 230000000254 damaging effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- ALRFYJWUVHBXLV-UHFFFAOYSA-N guaijaverin Natural products OC1COC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O ALRFYJWUVHBXLV-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- BDCDNTVZSILEOY-UHFFFAOYSA-N polystachoside Natural products OC1C(O)C(CO)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 3
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- QIAVRJHHAWLZNB-RLPYSRNMSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(e)-2,3,4,5-tetrahydroxy-6-[(e)-2,3,4,5,6-pentahydroxyhex-3-enoxy]hex-3-enoxy]chromen-4-one Chemical compound O1C2=CC(O)=CC(O)=C2C(=O)C(OCC(O)C(/O)=C(\O)C(O)COCC(O)C(/O)=C(\O)C(O)CO)=C1C1=CC=C(O)C(O)=C1 QIAVRJHHAWLZNB-RLPYSRNMSA-N 0.000 description 2
- 101000874334 Dalbergia nigrescens Isoflavonoid 7-O-beta-apiosyl-glucoside beta-glycosidase Proteins 0.000 description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 101000757733 Enterococcus faecalis (strain ATCC 700802 / V583) Autolysin Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 101000757734 Mycolicibacterium phlei 38 kDa autolysin Proteins 0.000 description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 101000805921 Strongylocentrotus purpuratus Upstream stimulatory factor Proteins 0.000 description 2
- 230000037338 UVA radiation Effects 0.000 description 2
- 101000671634 Xenopus borealis Upstream stimulatory factor 1 Proteins 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- QIARVOTYSDZZQL-UHFFFAOYSA-N avicularin Natural products OCC1OC(Oc2cc(O)c3C(=O)C(=C(Oc3c2)c4ccc(O)c(O)c4)O)C(O)C1O QIARVOTYSDZZQL-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229940095066 hydroxytyrosol Drugs 0.000 description 2
- 235000003248 hydroxytyrosol Nutrition 0.000 description 2
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 2
- 235000008777 kaempferol Nutrition 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100001183 nonphototoxic Toxicity 0.000 description 2
- 230000008832 photodamage Effects 0.000 description 2
- 150000004032 porphyrins Chemical class 0.000 description 2
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- DUBCCGAQYVUYEU-MBIBTLSJSA-N (2s,3s,4s,5r)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O DUBCCGAQYVUYEU-MBIBTLSJSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- PZZRDJXEMZMZFD-IEGSVRCHSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-IEGSVRCHSA-N 0.000 description 1
- PZZRDJXEMZMZFD-DUYPVGENSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)COC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-DUYPVGENSA-N 0.000 description 1
- COJRWHSKVYUZHQ-UHFFFAOYSA-N 3-(1-hydroxyethyl)phenol Chemical compound CC(O)C1=CC=CC(O)=C1 COJRWHSKVYUZHQ-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 241000242757 Anthozoa Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PIIOQVAAZCSCLQ-UHFFFAOYSA-N C1(=CC=CC=C1)O.CC(O)C1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)O.CC(O)C1=CC=CC=C1 PIIOQVAAZCSCLQ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- HDOMLWFFJSLFBI-UHFFFAOYSA-N Eriocitrin Natural products CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(Oc4c3)c5ccc(OC6OC(COC7OC(C)C(O)C(O)C7O)C(O)C(O)C6O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O HDOMLWFFJSLFBI-UHFFFAOYSA-N 0.000 description 1
- OMQADRGFMLGFJF-MNPJBKLOSA-N Eriodictioside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=C(O)C(O)=CC=2)O1 OMQADRGFMLGFJF-MNPJBKLOSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RPVIQWDFJPYNJM-UHFFFAOYSA-N Ganodermic acid Ja Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(O)C(O)C(CO)O2)O)C=C1O RPVIQWDFJPYNJM-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- LMFKRLGHEKVMNT-ZIEJDFEHSA-N Heliotrine Natural products C1C[C@H](O)[C@H]2C(COC(=O)[C@](O)(C(C)C)[C@H](C)OC)=CCN21 LMFKRLGHEKVMNT-ZIEJDFEHSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- POQICXMTUPVZMX-FWYGIPPASA-N Juglanin Natural products O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O POQICXMTUPVZMX-FWYGIPPASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- RPVIQWDFJPYNJM-MPPJEPTCSA-N Quercetin 3,4'-di-O-beta-D-glucopyranoside Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)c1c(O)cc(C2=C(O[C@H]3[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O3)C(=O)c3c(O)cc(O)cc3O2)cc1 RPVIQWDFJPYNJM-MPPJEPTCSA-N 0.000 description 1
- BDCDNTVZSILEOY-BQCJVYABSA-N Quercetin 3-arabinoside Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-BQCJVYABSA-N 0.000 description 1
- NSZQOXBBEWYGQH-UHFFFAOYSA-N Quercetin-3-rhamnosid Natural products CC1OC(O)C(O)C(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C1O NSZQOXBBEWYGQH-UHFFFAOYSA-N 0.000 description 1
- QJTYCCFDQWFJHU-UHFFFAOYSA-N Quercetin-5-O-beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C(O)=C(C=1C=C(O)C(O)=CC=1)O2 QJTYCCFDQWFJHU-UHFFFAOYSA-N 0.000 description 1
- PZZRDJXEMZMZFD-ODPGBAFUSA-N Reynoutrin Natural products O[C@H]1[C@H](O)[C@@H](O)CO[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-ODPGBAFUSA-N 0.000 description 1
- 241001493421 Robinia <trematode> Species 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- RDUAJIJVNHKTQC-UHFFFAOYSA-N UNPD183040 Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)OC(CO)C(O)C1O RDUAJIJVNHKTQC-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- SOSLMHZOJATCCP-PADPQNGGSA-N afzelin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2ccc(O)cc2)Oc2c(c(O)cc(O)c2)C1=O SOSLMHZOJATCCP-PADPQNGGSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical group O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- BDCDNTVZSILEOY-UXYNSRGZSA-N avicularin Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-UXYNSRGZSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000002032 cellular defenses Effects 0.000 description 1
- 150000001789 chalcones Chemical class 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 150000002016 disaccharides Chemical group 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- MPGWGYQTRSNGDD-UHFFFAOYSA-N hypericin Chemical compound OC1=CC(O)=C(C2=O)C3=C1C1C(O)=CC(=O)C(C4=O)=C1C1=C3C3=C2C(O)=CC(C)=C3C2=C1C4=C(O)C=C2C MPGWGYQTRSNGDD-UHFFFAOYSA-N 0.000 description 1
- 229940005608 hypericin Drugs 0.000 description 1
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 208000002440 photoallergic dermatitis Diseases 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 230000001443 photoexcitation Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 230000021715 photosynthesis, light harvesting Effects 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 125000004402 polyphenol group Chemical group 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229930010796 primary metabolite Natural products 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 1
- 150000003243 quercetin Chemical class 0.000 description 1
- RPVIQWDFJPYNJM-DEFKTLOSSA-N quercetin 3,4'-di-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1O RPVIQWDFJPYNJM-DEFKTLOSSA-N 0.000 description 1
- RDUAJIJVNHKTQC-UJECXLDQSA-N quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O[C@H](CO)[C@@H](O)[C@@H]1O RDUAJIJVNHKTQC-UJECXLDQSA-N 0.000 description 1
- LUGRJXSUUSMJEB-UHFFFAOYSA-N quercetin 3-O-rhamnoside Natural products OC1C(O)C(O)C(C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1 LUGRJXSUUSMJEB-UHFFFAOYSA-N 0.000 description 1
- PZZRDJXEMZMZFD-BWYUNELBSA-N quercetin-3-O-beta-D-xylopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-BWYUNELBSA-N 0.000 description 1
- SZDMSNWMQAMVTJ-UHFFFAOYSA-N quercetin-3-O-glucoside Natural products OC1OC(COC2=C(C(=O)c3cc(O)cc(O)c3O2)c4ccc(O)c(O)c4)C(O)C(O)C1O SZDMSNWMQAMVTJ-UHFFFAOYSA-N 0.000 description 1
- FZKBNCDAGYDHTP-UHFFFAOYSA-N quercetin-3-O-glycoside Natural products OC1C(O)C(O)C(O)OC1COC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O FZKBNCDAGYDHTP-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000004508 retinoic acid derivatives Chemical class 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 150000008505 β-D-glucopyranosides Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
不含氮的天然糖基化多酚作为保护剂防止紫外线辐照对结构的可光降解物质的影响的用途。
Description
背景技术
1.技术领域
本发明涉及根据权利要求1的前序部分的不含氮的天然糖基化多酚的用途。
2.相关现有技术的描述
从WO 03/097577SYNTH’E163中,已知含氮物质可用于保护敏感材料免受UV辐射的影响。
高等植物和低等真核生物,诸如海洋微型/大型藻类、珊瑚、水母等,合成对其生长、分裂和繁殖所必需的初级代谢产物(蛋白质和氨基酸、脂质和脂肪酸、多糖和寡糖)。它们占陆生和海洋生物的干重的超过90-95%。
还有一些次级代谢产物,它们不直接参与上述植物/海洋生物的主要功能,但是对于信号转导、细胞功能的协调以及对不断变化的环境条件(对所谓的生物和非生物胁迫)的防御和适应是必需的。例如,植物/海洋生物中的次级代谢产物开始于暴露于UV、X射线或超声波辐照、温度变化(冷或热)、重金属、盐和有机毒素成分、机械损伤等。它也由细菌、病毒或寄生虫感染或由食草动物和昆虫造成的损伤而引起。通常,次级代谢产物被认为是保护性、适应性和调节性(激素样)物质。据信,次级代谢产物在植物和低等海洋生物中起原始的“免疫系统”和“解毒网络”的作用。
到目前为止,所有已知的次级代谢产物(超过5,000种不同的物质)可以根据它们的化学结构分为三大类:
-苯丙素类(phenylpropanoids)(或乙丙素类)以及它们的衍生物,诸如简单的多酚(酸、醇和醛)、芳香族多酚(生物类黄酮、芪、姜黄素类、香豆素类等)和糖苷。它们含有碳、氢和氧原子,并形成含有多个羟基基团和糖苷部分(主要是鼠李糖、甘露糖、芸香糖等)的芳香或聚芳香结构。
-萜类,含有长的主要不饱和C-H链和C-H非芳香环的核
-含氮杂环,诸如生物碱、嘌呤、嘧啶、卟啉、叶绿素、黄素等。
大多数次级代谢产物可以以某种方式与太阳UV辐照相互作用:
-它们中的一些(例如,苯丙素类和它们的糖苷类以及生物类黄酮)专门保护生物结构免受UV和可见光(I型光反应)的损伤作用;
-它们中的一些(类黄酮、苯丙素类和萜类)优选地保护细胞和组织免受在分子氧存在下UV与有机物发生反应(II型光反应)后形成的活性氧物种(超氧阴离子自由基、羟基自由基、过氧化物和单线态氧)的损伤作用;
-它们中的一些(含氮杂环和萜类)利用UV、可见光或红外线辐照的能量来促进生物学上重要的光化学反应,诸如光合作用或血红蛋白或含萜类聚合物合成。它们被称为光敏剂。
-这些含氮的光敏剂(卟啉、二氢吡啶、氨基酸色氨酸及衍生物、维甲酸、嘌呤和嘧啶)广泛存在于不同的细胞和组织中,首先存在于人体皮肤细胞中。在图1中,示意性地示出了太阳光(光量子、UV、可见光或红外光)与皮肤中的生色团(CH)的相互作用的过程。CH转化成具有高于初始能量的其激发态(CH*)。
-激发态是一种寿命短暂的状态并且根据分子的电子结构、其共轭的芳香族“π”电子和整个分子的3D构型(芳香部分的平面或垂直位置的存在与否,以及糖苷部分的存在)以热、荧光或磷光的形式发射能量而转变成具有较低能量的基态。这些分子属于防晒剂,因为它们有效地清除太阳光而不会引发任何光化学反应。这些分子通常是光稳定的,因为它们不会转化成光化学衍生物并且它们不容易被太阳辐照破坏。在人类皮肤中,这些是黑色素(褐黑素)、氨基酸酪氨酸及其衍生物。另一方面,它们还可以是在由太阳光引发的II型光化学反应后形成的活性氧物种的有效清除剂。
在YONEYAMA等人的US 5,565,435中,提出了合成制备的糖基化多酚α-糖基槲皮素作为皮肤保护剂用于化妆品。该方案基于这样一个假设,即天然糖苷配基槲皮素及其合成衍生物α-糖基槲皮素在UV区域中具有有2个最大值的吸收光谱。未提供具体数据来支持他们的假设。
发明内容
本发明的目的是提供来源于药用植物的天然糖基化聚芳多酚(GPP),用作保护人类皮肤免受UV辐照的物理、化学和生物保护的非光毒性活性物质。由于由聚芳多酚部分和糖部分组成的特定化学结构,GPP有效地吸收UVB光(280-320nm)和UVA光(320-400nm)两者,从而对广谱UV辐照提供有效的物理/化学屏蔽。糖部分的存在提供了它们对UVA辐照的更高的稳定性,因而确保了持久的光保护,因此它们是光稳定分子,并且与大多数合成防晒剂不同,它们不会被UVA光破坏。作为有效的抗氧化剂,GPP防止活性氧物种驱动的光化学反应,从而防止对皮肤细胞和细胞外基质的II型光毒性。GPP具有抗炎特性,可阻断UV引起的皮肤炎症。
-我们在本文提出了属于糖基化苯丙素类/生物类黄酮的类别的植物/植物细胞/海洋生物来源的次级代谢产物,其通过上述太阳光与具有防晒和自由基清除特性的光稳定且非光毒性的保护剂的相互作用机制而具有宽带光保护特性。
-与此同时,CH*可以是光敏剂(PS),它会转移其过多的能量以引发光化学反应,直接与生物活性分子作用,从而引起对DNA、多糖和蛋白质的自由基驱动的损伤(I型),或者对分子氧作用,分子氧从三重态转化为单重态(激发态)(II型)。在II型光诱导反应下形成的活性氧物种可用于合成过程,但主要地,由于它们对蛋白质、DNA、多糖和脂质的损伤潜能,因而它们是有害的。含氮植物或海洋生物来源的物质具有潜在的危险性,因为它们可能具有化学光毒性,可能引起光过敏,增加皮肤敏感性,引起炎症、发红和瘙痒。但是,这些物质可用于皮肤肿瘤的光动力疗法、慢性炎症性皮肤病、慢性黑变作用缺陷和皮肤感染。
本发明通过使用包含权利要求1的特征的天然糖基化多酚解决了所提出的问题。
从化学动力学的角度来看,非含氮苯丙素或多酚化合物应具有相当高的活化能,并因此需要UV辐照以获得激发态。由于它们的高度共轭的芳香部分具有稳定的“π”构型,因此它们的激发态寿命更长,并且能量在该特定分子的空间内消散。它们的芳香环主要位于垂直位置,这有利于分子内的电子“俘获”。由于电子逃逸的可能性,糖苷部分的添加使得构型甚至更加复杂。
对于要求保护的本发明,提供了数据以支持令人惊讶的发现,即确定的天然糖基化多酚由于多种原因提供了最佳的光保护。它们有效地吸收两个光谱区域:UVA和UVB中的宽带范围的UV光。它们吸收UVA+UVB的效力可与合成防晒剂(例如,二苯甲酮-3)的黄金标准相当。吸收效力表示为SPF(防晒系数),用于UVB范围,代表整个UVB光谱内吸收的积分。吸收效力还计算为UVA/UVB比值,表明为了提供适当的UVA保护该比值应大于0.5至最高1.2。
有具有π键的稠合结构的所有聚芳分子(同样地α-糖基化槲皮素)都具有在UV光谱范围内有两个峰的吸收光谱。但是,光谱峰下的积分平方通常是很小的值(窄且高的峰或宽且低的峰),并且不符合国际公认的SPF和UVA/UVB值。因此,这些物质不能被认为是有效的且宽带UV屏蔽剂。参见下面表1中有关儿茶素、桑色素、槲皮素和黄芩素相比花旗松素、毛蕊花苷、绒花酸和白藜芦醇的比较数据。
表1.(糖基化和非糖基化植物多酚对宽带紫外线B和A的吸收)
防晒剂 | SPF1(250μM) | SPF2(10%) | UVA/UVB |
糖基化多酚 | |||
花旗松素 | 6.38±0.12 | 8.39±0.14 | 0.46 |
芸香苷 | 5.25±0.13 | 3.44±0.16 | 1.20 |
水飞蓟宾 | 6.44±0.14 | 5.34±0.16 | 0.46 |
毛蕊花苷 | 8.25±0.09 | 5.29±0.09 | 0.59 |
绒花酸 | 11.83±0.12 | 6.79±0.12 | 0.51 |
刺槐素 | 4.86±0.22 | 6.85±0.19 | 0.77 |
黄芩素 | 3.65±0.12 | 5.41±0.12 | 1.14 |
非糖基化多酚 | |||
桑色素 | 2.63±0.08 | 3.48±0.12 | 1.70 |
表儿茶素 | 0.10±0.02 | 0.14±0.04 | 0.25 |
白杨素 | 1.62±0.07 | 2.55±0.07 | 0.96 |
SPF-防晒系数,对应于针对微摩尔(SPF1)和重量%(SPF2)浓度的防晒剂计算的UVB吸收。UVA/UVB-UVA与UVB吸收的比值。
大多数聚芳多酚对暴露于UV辐照是不稳定的,因此它们会在短时间内遭受光破坏(槲皮素、白藜芦醇、山奈酚等)。
根据本发明的多酚相对于现有技术(特别是相对于YONEYAMA等人的US 5,565,435)具有以下优点:
槲皮素及其α-糖基化衍生物是光不稳定的,并且如果在暴露于阳光1-10min之后不重新施用,就将无法保护人类皮肤免受UV损伤。这意味着现有的专利分子提供了短期的不受控制的保护,这不符合对某些光保护的要求和对适当保护的期望。
根据本发明的所选天然糖基化多酚由于其高的光稳定性而提供了长时间的保护。
绝大多数的聚芳多酚,特别是合成的聚芳多酚,由于引起对皮肤细胞的光化学损伤而表现出确定的光化学毒性(参见表3)。这对于槲皮素及其α-糖基化衍生物、白藜芦醇、查尔酮和许多其他化合物都是如此。光化学毒性的现象取决于UV诱导的母体分子的破坏和由所形成的代谢物施加的细胞毒性。
根据本发明的所选天然糖基化多酚不促进光化学反应,因此不产生任何光细胞毒性。它们对于人类用途安全得多。
具有α键的合成糖基不会经受天然人类酶β-糖苷酶的酶促代谢。因此,它们在人类皮肤内保持不代谢,这极大地增加了对异生物质(外源物质)的不良皮肤反应的风险。
根据本发明的天然糖基化多酚是β-糖苷酶的底物,并且通常通过正常代谢途径代谢和排泄,这不涉及不良皮肤反应的任何风险。它们具有更高的生物利用性和生物相容性,同时毒性更低。
因此,根据本发明的多酚克服了现有技术中已知的合成光保护剂的安全性和效力缺陷。
此外,根据本发明的具有宽带光保护特性的天然糖基化多酚比合成的聚芳多酚便宜得多,因为靶向糖基化是耗费时间和金钱的过程,经常产生具有随机位置的糖部分的不受控的糖苷混合物。如果一个或多个OH-基团被糖部分取代,则这可能会妨碍多酚的抗氧化能力;或者在可酶促裂解的β-键被不可酶促裂解的α-键取代的情况下,这可能会妨碍它们在人体细胞中的自然代谢。
天然生物合成的GPP是在暴露于太阳UV辐射后在植物中诱导的最初的GPP。多酚的所有天然糖基化O-衍生物在位置3或者很罕见地在位置4具有单糖或二糖部分(广寄生苷(Avicularin)(槲皮素-3-O-α-L-阿拉伯呋喃糖苷)、CTN-986番石榴苷(Guaijaverin)(槲皮素3-O-阿拉伯糖苷)、泽漆新苷(Heliosin)(槲皮素3-双半乳糖苷)、金丝桃苷(Hyperoside)(槲皮素3-O-半乳糖苷)、异槲皮苷(Isoquercetin)(槲皮素3-O-葡萄糖苷)、Miquelianin(槲皮素3-O-葡萄糖醛酸苷)、槲皮素3,4'-二葡萄糖苷、槲皮素-3-槐糖苷、槲皮苷(Quercitrin)(槲皮素3-O-鼠李糖苷)、芸香苷(Rutin)(槲皮素芸香糖苷)、Reinutrin(槲皮素-3-D-木糖苷)、绣线菊苷(Spiraeoside)(槲皮素4'-O-葡萄糖苷)、Taxillusin(槲皮素的没食子酰3-O-葡萄糖苷)或苯丙素苷(毛蕊花苷(verbascoside)—用苯乙醇酚羟基酪醇(phenylethanoidhydroxytyrosol)、苯丙素咖啡酸和糖α-L-鼠李糖基-(3)-β-D-吡喃葡萄糖形成的酯。所有多酚基团均不涉及;teupolioside—通过咖啡酸和4,5-羟基苯乙醇结合到β-D-吡喃葡萄糖苷、鼠李糖和半乳糖形成的酯和糖苷)或糖基化的芪类(虎杖苷(polydatin)—白藜芦醇-3-O-β-D-吡喃葡萄糖苷)。
该位置使它们易受II相代谢酶的影响,该II相代谢酶会将硫酸根、甲基或葡萄糖醛酸残基转移至多酚分子,并将它们从活生物体中排出。α糖基化使植物来源的分子不被代谢,因此对人类的毒性很大。
植物生物合成过程中3和4位置中的天然糖基化使得产生高度光稳定的衍生物,其不同于在暴露于阳光模拟的UVB+UVA辐照后很容易被破坏的它们的糖苷配基(槲皮素、杨梅素(myricetin)、山奈酚(kaempherol)、白藜芦醇和黄芩素),如在下表2中可以看到的。
表2.阳光模拟的UV辐照对防晒剂SPF值的影响(防晒剂的光稳定性)
将放置于3.5cm皮氏培养皿中的五十μM防晒剂溶液用66%UVA+33%UVB辐照1、3、20和40min。UV辐照的最终剂量分别为0.15、0.45、3.0和6.0J/cm2。相对于背景SPF,*p<0.05;相对于背景SPF,**p<0.01。
本发明的其他有利实施方式可以评述如下:
在优选的实施方式中,多酚是聚芳多酚。
在另一实施方式中,多酚不包含醛结构。已令人惊讶地发现,由于光激发的能量降低,多酚中醛基的存在使其更容易受到光破坏的影响。
优选地,酚是糖基化的苯丙素或苯乙醇酚(phenylethanoid)。在植物、培养的植物细胞或海洋生物中,当它们被UV光辐照时,首先通过苯丙素途径形成天然糖基化苯丙素类。令人惊讶地发现,它们是主要的天然光保护剂。苯丙素/类黄酮合成然后糖基化的代谢途径极为复杂且至今还不清楚。化学合成不会得到糖苷部分的天然含量、位置和构象。此外,这种合成非常昂贵,并且模仿天然分子的合成糖苷是商业上不可接受的。
在另一实施方式中,多酚是毛蕊花苷或teupolioside。
在又一实施方式中,多酚是糖基化的类黄酮、黄酮醇或黄烷醇。
在另一实施方式中,多酚是芸香苷、黄芩素、桑色素或花旗松素。
多酚也可以是糖基化的芪类化合物,优选虎杖苷。
在另一实施方式中,多酚是从陆生植物或海洋植物或其他海洋生物的提取物中获得的。在另一实施方式中,多酚是从植物细胞培养物的提取物中获得的。
在另一实施方式中,使用几种多酚的混合物。这具有覆盖更宽的UV辐照光谱的优点。
优选地,糖基化多酚的糖部分是鼠李糖、阿拉伯糖或甘露糖。这些糖部分令人惊讶地显示出比葡萄糖或果糖更好的结果。
优选地,根据本发明的用途是针对宽带紫外线辐照的外用保护。可替代地,该用途可以是针对太阳UV辐照的生物保护。
在另一实施方式中,多酚的用途是用于改善皮肤的天然光保护相关的抗氧化特性,特别是保护皮肤表面脂溶性抗氧化剂免受光降解的影响。
优选地,将多酚用作防晒组合物中的组分。多酚可以有利地成为外用化妆品组合物的组分,外用化妆品组合物优选为凝胶、喷雾、乳霜或洗剂的形式。
多酚可以与具有光保护要求的外用化妆品组合物(如凝胶、喷雾、乳霜和洗剂)混合,以提高外部施用的药物(诸如皮质类固醇、非甾体抗炎药(NSAID)、抗生素和抗病毒药物)的光稳定性。
优选地,根据本发明的用途是用于防止UV辐照的长期生物学后果,例如,皮肤发红、肿胀、疼痛和过早老化。
优选地,将多酚与常规物理防晒剂(优选TiO2或ZnO)混合,以增强UV防护并减弱物理防晒剂毒性。
多酚可以有目的地以至少5μM,优选至少10μM的浓度施用。该浓度可以有目的地为至少20μM,优选至少40μM。
有目的地,多酚以至多500μM,优选至多100μM的浓度施用。有目的地,该浓度为至多80μM,优选至多50μM。
在优选的实施方式中,多酚还包括轻水,优选具有含量小于125ppm的2H。
在另一特定实施方式中,多酚还包括水,该水含有:
a)至少500ppm的18O和至多1100ppm的18O;以及
b)至少20ppm的2H和至多90ppm的2H。
用于治疗或预防由于暴露于氧化而引起的皮肤老化的方法,包括施用有效量的由根据本发明的用途所定义的多酚。
该方法优选用于保护皮肤免受光反应的影响。该方法还可以用于减少或防止氧化影响对皮肤的损伤。多酚可以以至少5μM,优选至少10μM的浓度施用。有目的地,该浓度为至少20μM,优选至少40μM。
多酚可以以至多500μM,优选至多100μM的浓度施用。有目的地,该浓度为至多80μM,优选至多50μM。
在具有光保护特性的外用化妆品组合物(如凝胶、喷雾、乳霜和洗剂)中的分离的天然糖基化GPP和/或提取物中的GPP可以用于光敏性人群,例如学步幼儿、儿童、孕妇、免疫抑制的人群和老年人。
具体实施方式
下列实施例更详细地阐明了本发明。
实施例1:宽带防晒凝胶(SPF-B>50,并且UV-A/UV-B比值>1)
实施例2:宽带防晒稀乳霜(特别是用于孕妇):SPF-B>50,并且UV-A/UV-B比值>0.5<1
实施例3:宽带防晒乳(特别是用于婴儿和儿童),SPF-B>50,并且UV-A/UV-B比值>0.5<1.0
实施例4:宽带防晒喷雾(30<SPF-B<50且UV-A/UV-B比值>1)
尽管已经结合本发明的特定实施方式描述了本发明,但是显然许多替代、修改和变化对于本领域技术人员将是显而易见的。因此,旨在涵盖落入所附权利要求的范围内的所有这些替代、修改和变化。
应当理解的是,为清楚起见在各个实施方式的上下文中描述的本发明的某些特征也可以以组合的形式在一个实施方式中提供。相反地,为简洁起见,在一个实施方式的上下文中描述的本发明的各种特征,也可以单独地或以任何合适的子组合的形式或合适地在本发明的任何其他所述实施方式中提供。在各种实施方式的上下文中描述的某些特征不应被认为是那些实施方式的必要特征,除非该实施方式没有那些要素就不能发挥作用。
Claims (33)
1.不含氮的天然糖基化多酚作为保护剂防止紫外线辐照对结构的可光降解物质的影响的用途。
2.根据权利要求1所述的用途,其特征在于,所述多酚是聚芳多酚。
3.根据权利要求1或2所述的用途,其特征在于,所述多酚不包含醛结构。
4.根据权利要求1至3中任一项所述的用途,其特征在于,所述酚是糖基化的苯丙素或苯乙醇酚。
5.根据权利要求4所述的用途,其特征在于,所述多酚是毛蕊花苷或teupolioside。
6.根据权利要求1至3中任一项所述的用途,其特征在于,所述多酚是糖基化的类黄酮、黄酮醇或黄烷醇。
7.根据权利要求6所述的用途,其特征在于,所述多酚是芸香苷、黄芩素、桑色素或花旗松素。
8.根据权利要求1至3中任一项所述的用途,其特征在于,所述多酚是糖基化的芪类化合物,优选虎杖苷。
9.根据权利要求1至8中任一项所述的用途,其特征在于,所述多酚是从陆生植物或海洋植物或其他海洋生物的提取物中获得的。
10.根据权利要求1至8中任一项所述的用途,其特征在于,所述多酚是从植物细胞培养物的提取物中获得的。
11.根据权利要求1至10中任一项所述的用途,其特征在于,使用几种多酚的混合物。
12.根据权利要求1至11中任一项所述的用途,其特征在于,所述糖基化多酚的糖部分是鼠李糖、阿拉伯糖或甘露糖。
13.根据权利要求1至12中任一项所述的用途,用于针对宽带紫外线辐照的外用保护。
14.根据权利要求1至13中任一项所述的用途,用于针对太阳UV辐照的生物保护。
15.根据权利要求1至14中任一项所述的多酚的用途,用于改善皮肤的天然光保护相关的抗氧化剂特性,特别是保护皮肤表面脂溶性抗氧化剂免受光降解的影响。
16.根据权利要求1至15中任一项所述的用途,其特征在于,所述多酚用作防晒组合物中的组分。
17.根据权利要求1至16中任一项所述的用途,其特征在于,所述多酚是外用化妆品组合物的组分,所述外用化妆品组合物优选为凝胶、喷雾、乳霜或洗剂的形式。
18.根据权利要求1至17中任一项所述的用途,其特征在于,将所述多酚与具有光保护性要求的外用化妆品组合物如凝胶、喷雾、乳霜和洗剂混合,以提高外部施用的药物诸如皮质类固醇、非甾体类抗炎药(NSAID)、抗生素和抗病毒药物的光稳定性。
19.根据权利要求1至18中任一项所述的用途,用于防止UV辐照的长期生物学后果,如皮肤发红、肿胀、疼痛和过早老化。
20.根据权利要求1至19中任一项所述的用途,其特征在于,将所述多酚与常规物理防晒剂优选TiO2或ZnO混合,以增强UV防护并减弱物理防晒剂毒性。
21.根据权利要求1至20中任一项所述的用途,其特征在于,所述多酚以至少5μM,优选至少10μM的浓度施用。
22.根据权利要求21所述的用途,其特征在于,所述浓度为至少20μM,优选至少40μM。
23.根据权利要求1至22中任一项所述的用途,其特征在于,所述多酚以至多500μM,优选至多100μM的浓度施用。
24.根据权利要求23所述的用途,其特征在于,所述浓度为至多80μM,优选至多50μM。
25.根据权利要求1至24中任一项所述的用途,其特征在于,其包括轻水,优选具有含量小于125ppm的2H。
26.根据权利要求1至25中任一项所述的用途,其特征在于,其包括水,所述水含有:
a)至少500ppm的18O和至多1100ppm的18O;以及
b)至少20ppm的2H和至多90ppm的2H。
27.一种用于治疗或预防由于暴露于氧化而引起的皮肤老化的方法,所述方法包括施用有效量的根据权利要求1至26中任一项所述的多酚。
28.根据权利要求27所述的方法,用于保护皮肤免受光反应的影响。
29.根据权利要求27所述的方法,用于减少或防止氧化影响对皮肤的损伤。
30.根据权利要求27至29中任一项所述的方法,其特征在于,所述多酚以至少5μM,优选至少10μM的浓度施用。
31.根据权利要求30所述的方法,其特征在于,所述浓度为至少20μM,优选至少40μM。
32.根据权利要求27至31中任一项所述的方法,其特征在于,所述多酚以至多500μM,优选至多100μM的浓度施用。
33.根据权利要求32所述的方法,其特征在于,所述浓度为至多80μM,优选至多50μM。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CH2017/000048 WO2018209449A1 (en) | 2017-05-18 | 2017-05-18 | Use of naturally glycosylated polyphenols as protective agents against the effects of ultraviolet irradiation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110636830A true CN110636830A (zh) | 2019-12-31 |
Family
ID=58992561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780090820.6A Pending CN110636830A (zh) | 2017-05-18 | 2017-05-18 | 天然糖基化多酚作为抗紫外线辐照影响的保护剂的用途 |
Country Status (5)
Country | Link |
---|---|
US (1) | US11504320B2 (zh) |
EP (1) | EP3624763A1 (zh) |
CN (1) | CN110636830A (zh) |
CA (1) | CA3063229A1 (zh) |
WO (1) | WO2018209449A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112569221A (zh) * | 2020-12-15 | 2021-03-30 | 天津中医药大学 | 千叶素a在制备防治皮肤光老化的药物或护肤品中的用途 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116546962A (zh) * | 2020-11-30 | 2023-08-04 | 莱雅公司 | 护肤组合物 |
WO2023093998A1 (en) | 2021-11-26 | 2023-06-01 | Medena Ag | Composition, in particular cosmetic formulation, comprising a verbascoside extract |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ264108A (en) * | 1994-07-27 | 1997-05-26 | Comvita New Zealand Ltd | Uv sun screen composition comprising at least one flavonoid (or derivative); uses in various compositions |
JP2000319154A (ja) * | 1999-05-06 | 2000-11-21 | Nippon Menaade Keshohin Kk | 光毒性抑制剤 |
CN101137416A (zh) * | 2005-03-05 | 2008-03-05 | 谢尔盖帕夫洛维奇·索洛维约夫 | 富含1h216o的化妆品组合物 |
US20090028969A1 (en) * | 2006-02-28 | 2009-01-29 | Gerard Sene | Compostion for treating skin |
KR20130049040A (ko) * | 2011-11-03 | 2013-05-13 | (주)아모레퍼시픽 | 탁시폴린 배당체를 유효성분으로 함유하는 화장료 조성물 및 작약 추출물의 추출방법 |
EP2257266B1 (en) * | 2008-04-01 | 2016-03-16 | Lodovico Gianluca Braguti | Compositions designed to prevent/protect against photoallergic and phototoxic skin reactions |
WO2016113659A1 (en) * | 2015-01-13 | 2016-07-21 | Sederma | Use of plant cells of leontopodium alpinum for a cosmetic treatment and corresponding active ingredient |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3134233B2 (ja) | 1991-07-26 | 2001-02-13 | 株式会社林原生物化学研究所 | α−グリコシル ケルセチンとその製造方法並びに用途 |
FR2839717A1 (fr) | 2002-05-15 | 2003-11-21 | Synth E163 | Compose chimique de derive azote de chalcone, procede d'obtention d'un tel compose chimique, composition cosmetique et/ou filtrante, contenant un tel compose chimique |
EP1855699B1 (en) * | 2005-03-11 | 2012-08-15 | Sergey Pavlovich Soloviev | Light pharmaceutical water and therapeutic compositions and methods thereof |
JP2006306804A (ja) * | 2005-04-28 | 2006-11-09 | Kanebo Cosmetics Inc | シワ形成抑制剤 |
EP1736167B1 (en) * | 2005-06-20 | 2018-03-21 | I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. | Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use |
EP1736166B2 (en) * | 2005-06-20 | 2018-02-28 | I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. | Extracts from Ajuga reptans cell lines, their preparation and use |
CN102727411B (zh) * | 2012-07-11 | 2014-05-21 | 福建春伦茶业集团有限公司 | 基于天然植物成份的防晒霜配方及其制备方法 |
CN104910219B (zh) * | 2014-12-24 | 2018-09-21 | 中国科学院兰州化学物理研究所 | 一种苯乙醇苷类抗辐射化合物及其制备方法和应用 |
US20180280343A1 (en) * | 2015-10-02 | 2018-10-04 | Theresa PACHECO | Topical silibinin formulations and uses therefor |
CN106109307A (zh) * | 2016-07-15 | 2016-11-16 | 张进 | 一种清爽无刺激的防晒剂及其制备方法 |
-
2017
- 2017-05-18 EP EP17727075.8A patent/EP3624763A1/en active Pending
- 2017-05-18 CN CN201780090820.6A patent/CN110636830A/zh active Pending
- 2017-05-18 WO PCT/CH2017/000048 patent/WO2018209449A1/en active Search and Examination
- 2017-05-18 US US16/613,858 patent/US11504320B2/en active Active
- 2017-05-18 CA CA3063229A patent/CA3063229A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ264108A (en) * | 1994-07-27 | 1997-05-26 | Comvita New Zealand Ltd | Uv sun screen composition comprising at least one flavonoid (or derivative); uses in various compositions |
JP2000319154A (ja) * | 1999-05-06 | 2000-11-21 | Nippon Menaade Keshohin Kk | 光毒性抑制剤 |
CN101137416A (zh) * | 2005-03-05 | 2008-03-05 | 谢尔盖帕夫洛维奇·索洛维约夫 | 富含1h216o的化妆品组合物 |
US20090028969A1 (en) * | 2006-02-28 | 2009-01-29 | Gerard Sene | Compostion for treating skin |
EP2257266B1 (en) * | 2008-04-01 | 2016-03-16 | Lodovico Gianluca Braguti | Compositions designed to prevent/protect against photoallergic and phototoxic skin reactions |
KR20130049040A (ko) * | 2011-11-03 | 2013-05-13 | (주)아모레퍼시픽 | 탁시폴린 배당체를 유효성분으로 함유하는 화장료 조성물 및 작약 추출물의 추출방법 |
WO2016113659A1 (en) * | 2015-01-13 | 2016-07-21 | Sederma | Use of plant cells of leontopodium alpinum for a cosmetic treatment and corresponding active ingredient |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112569221A (zh) * | 2020-12-15 | 2021-03-30 | 天津中医药大学 | 千叶素a在制备防治皮肤光老化的药物或护肤品中的用途 |
CN112569221B (zh) * | 2020-12-15 | 2023-01-17 | 天津中医药大学 | 千叶素a在制备防治皮肤光老化的药物或护肤品中的用途 |
Also Published As
Publication number | Publication date |
---|---|
EP3624763A1 (en) | 2020-03-25 |
US11504320B2 (en) | 2022-11-22 |
WO2018209449A1 (en) | 2018-11-22 |
CA3063229A1 (en) | 2018-11-22 |
US20200146962A1 (en) | 2020-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1156770B1 (en) | Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof | |
KR100810589B1 (ko) | 4-하이드록시페닐-알파-d-글루코피라노사이드를 함유하는피부과용 국소제 | |
EP1400579A2 (de) | Zubereitung mit antioxidanten Eigenschaften | |
EP1363594A1 (de) | Kosmetische formulierung enthaltend flavonoid-derivate | |
US20130295036A1 (en) | Method of using wood extracts in cosmetic and hygiene products | |
US20110256115A1 (en) | Hydrosoluble [6)o-alpha-d-glcp-(1->]n-6-o-beta-d-glcp-(1->-phenolic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds | |
CN110636830A (zh) | 天然糖基化多酚作为抗紫外线辐照影响的保护剂的用途 | |
KR101201916B1 (ko) | 효소반응에 의한 쓴 메밀 새싹추출물의 제조방법 및 그 추출물을 유효성분으로 함유하는 미백 및 항산화용 화장료 조성물 | |
US20050042186A1 (en) | All natural sunscreen lotion | |
KR100898307B1 (ko) | 피부 노화를 억제하여 항산화 효과를 가지는 화장료 조성물 | |
Menéndez-Perdomo et al. | Phyllanthus plants in photoprotection: a broad spectrum of molecular mechanisms | |
KR102356144B1 (ko) | 피부 미백 및 주름 개선용 건강기능식품 및 화장료 조성물 | |
JP2023038358A (ja) | 化粧用組成物、美容組成物、関節保護組成物、組成物 | |
KR102471694B1 (ko) | 강황 추출물을 함유하는 블루라이트 차단용 조성물 | |
EP2535087A2 (en) | Cosmetic, pharmaceutical or nutraceutical formulations containing antioxidant molecules and polymeric materials | |
Bose et al. | The use of quercetin and curcumin in skin care consumer products | |
JPH01308476A (ja) | 紫外線吸収剤 | |
KR20090002371A (ko) | 피부 진정 효과를 가지는 화장료 조성물 | |
CN110251501A (zh) | 一种益母草碱酚酸离子盐及其制备方法与应用 | |
KR101777368B1 (ko) | 월계화 추출물을 유효성분으로 함유하는 피부 미백 화장료 조성물 | |
KR20050007883A (ko) | 녹차 폴리페놀과, 아스코르빈산 또는 그 유도체를함유하는 피부 광 손상 방지용 조성물 | |
Secerli et al. | The Action Mechanisms of Polyphenols in the Prevention and Treatment of Skin Diseases | |
TWI736818B (zh) | 仙茅萃取物用於製備具有皮膚美白及保護dna活性之組成物的用途 | |
KR20160063002A (ko) | 호두 나무 추출물을 함유하는 자외선 차단용 화장료 조성물 | |
KR101540640B1 (ko) | 에스큘린 용해물 및 이를 포함하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |